Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a research letter to the British Journal of Surgery (BJS) a team of plastic surgeons reveal the effect of the COVID-19 pandemic on skin cancer surgery in the UK.

A doctor looks at the moles on someone's back

Abhilash Jain, Associate Professor of Plastic and Hand Surgery at NDORMS, was the senior author that conducted a multi-centre, prospective cohort study and survey of Plastic Surgeons. 

A national audit of skin cancer excisions by Plastic Surgeons was carried out throughout lockdown (March 16 – June 14 2020), and compared to a control - data collected immediately prior to lockdown (March 16 – 22 ) while normal NHS activities were still being undertaken. Data on 2050 patients from 32 Plastic Surgery units were included, as well as consecutive monthly surveys of Plastic Surgeons from 34 units to confirm trends. 

The study found that all skin cancer treatment was negatively affected by the pandemic:

  • The median number of general anaesthetic (GA) lists per week per institution fell from 3 pre-lockdown to 0⋅5 in April
  • Local anaesthetic (LA) lists were reduced in April and May but recovered in June.
  • The number of non-melanoma skin cancer’s (NMSC) treated per week fell by 27-47% throughout April
  • Excision of Squamous cell carcinomas (71%) was prioritised over basal cell carcinomas (28%) 

Abhilash said: “Overall we saw a lower number of surgeries for tumours taking place. At the same time there was a reduction in Moh’s surgery, radiotherapy services and fewer patients being offered immunotherapy. Long term the risk of untreated skin cancer may now be considered greater than COVID-19 and we would urge that all cancer services be resumed urgently.”

 

Similar stories

Oxford-Bristol Myers Squibb Fellowships awarded to NDORMS researchers

Six researchers from the Botnar Research Centre and the Kennedy Institute of Rheumatology at NDORMS have been awarded fellowships as part of the Oxford-Bristol Myers Squibb Fellowship Programme, providing them an opportunity to gain exposure to the field of commercial drug discovery and development.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

NDORMS researchers join new multidisciplinary oncology research project

OPTIMA aims to improve treatment for patients with prostate, breast and lung cancer through artificial intelligence

Professor David Beard awarded BOA Honorary Fellowship

Professor of Musculoskeletal and Surgical Science, David Beard, has been awarded an Honorary Fellowship by the British Orthopaedic Association.

Farewell to Angela, NDORMS Head of Administration

Angela Truesdale, who has retired from her role as Head of Administration at NDORMS will be fondly missed by all her colleagues and across the division.

Researchers from the Kennedy Institute awarded MRC funding

Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.